The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,480.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 40.00 (0.897%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,480.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BF&M Strategic Review Conclusion

30 Jan 2023 07:00

RNS Number : 1765O
Camellia PLC
30 January 2023
 

30 January 2023

Camellia Plc

 

(the "Company" or the "Group")

 

Associate Company Update

 

Camellia Plc (CAM.L) notes that its 36.9% owned associate company, BF&M Limited ("BF&M"), a listed Bermudian insurance business, has issued a statement that it has concluded its previously announced strategic review. The BF&M Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all BF&M shareholders, that BF&M remains in a strong capital position, has the right strategic plan already in place and a foundation for growth. BF&M remains focussed on taking decisive steps to create value for its shareholders. The full text of BF&M's announcement can be found in Appendix 1 to this announcement.

 

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

  

Appendix 1

BF&M Concludes Strategic Review

 

Hamilton, Bermuda, 7 December 2022 - BF&M Limited ("BF&M", "the BF&M Group" or "the Company") today announced that its Board of Directors (the "Board") concluded its previously announced review of strategic alternatives (the "Strategic Review"). After a comprehensive process with the assistance of Desjardins Capital Markets, the Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all shareholders.

 

Anthony Joaquin, Acting Chairman of the Board, said, "During our review, the Board assessed a comprehensive range of potential outcomes. Ultimately, this process reinforced our confidence that BF&M has the right strategic plan already in place to maximize value for shareholders. With this evaluation concluded, the Board is fully committed to supporting Abigail and the rest of the Company's leadership team as they continue to execute this plan."

 

Abigail Clifford, Chief Executive Officer, said, "BF&M is entering 2023 with a strong capital position and foundation for growth, including the highest AM Best financial strength rating of any domestic insurers operating in Bermuda and the Caribbean. We remain focused on taking decisive steps to create value for shareholders, while providing best-in-class support to our clients as they navigate a challenging economic environment and positioning BF&M as an employer of choice."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKLLLXFLFBBF
Date   Source Headline
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc
8th Oct 20205:15 pmRNSUpdate on African allegations
7th Oct 202011:00 amRNSDirector/PDMR Shareholding
25th Sep 20209:58 amRNSInterim Report 2020
25th Sep 20207:00 amRNSHalf-year Report
15th Sep 202010:53 amRNSNotice of Interim Results
17th Aug 20201:55 pmRNSAsset Disposal Amendment
17th Aug 202011:17 amRNSAsset Disposal
10th Jun 20201:03 pmRNSCorrection to Result of AGM
10th Jun 202012:24 pmRNSResult of AGM
10th Jun 202011:30 amRNSAGM Trading Statement
15th May 202011:00 amRNSAnnual Report and Notice of Annual General Meeting
7th May 20203:18 pmRNSFinal Results
27th Apr 20207:00 amRNSTrading update
1st Apr 202012:00 pmRNSTrading update
26th Mar 20204:37 pmRNSPrice Monitoring Extension
6th Mar 20207:00 amRNSDirectorate Changes
21st Jan 20207:00 amRNSTrading Update
15th Aug 201910:51 amRNSInterim Report 2019
15th Aug 20197:00 amRNSHalf-year Report
7th Jun 201911:00 amRNSResult of AGM
6th Jun 201911:30 amRNSAGM Trading Statement
15th Apr 201912:13 pmRNSAnnual Report and Notice of AGM
11th Apr 20197:00 amRNSFinal Results
21st Mar 20194:40 pmRNSSecond Price Monitoring Extn
21st Mar 20194:35 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSTrading update
23rd Oct 20187:00 amRNSTrading Update
29th Aug 201811:40 amRNSInterim Report 2018
24th Aug 20187:00 amRNSHalf-year Report
8th Jun 201812:20 pmRNSResult of AGM
7th Jun 201811:30 amRNSAGM Trading Statement
25th Apr 20184:00 pmRNSAnnual Report and Notice of AGM
20th Apr 20181:57 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSFinal Results
21st Mar 20187:00 amRNSNotice of Results
22nd Dec 20179:42 amRNSDirectorate Change
6th Dec 201712:28 pmRNSTrading Statement
14th Nov 20173:00 pmRNSHolding(s) in Company
29th Aug 20173:20 pmRNSInterim report 2017
25th Aug 20177:00 amRNSHalf-year Report
2nd Jun 20171:13 pmRNSResult of AGM
1st Jun 201711:30 amRNSAGM Statement
11th May 20177:00 amRNSUpdate on Duncan Lawrie
2nd May 20172:05 pmRNSAnnual Financial Report
27th Apr 20177:00 amRNSFinal Results
21st Apr 20175:03 pmRNSUpdate on Duncan Lawrie
19th Dec 20167:00 amRNSUpdate on Duncan Lawrie
22nd Nov 20165:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.